Articles On Resonance Health (ASX:RHT)

Resonance Health (ASX:RHT) has been contracted to provide liver-fat quantification services for Invictus Ops, a wholly-owned subsidiary of VGI Health Technology, for its clinical study of a potential new treatment for NASH.

Medicinal cannabis stock Cann Group (ASX:CAN) has scored a regulatory milestone, after being granted a GMP licence to manufacture CBD therapeutic goods in its Southern facility in Victoria. The GMP (or Good Manufacturing Practice) license w...

ASX investors got back in the risk saddle on Wednesday, with steady gains across the large cap indexes and a 1.7% jump for the microcap Emerging Companies index. The catalyst appeared to be comments from US Fed Chair Jerome Powell overnight...

The ASX is down -0.3% today with the information technology sector taking the cake for the biggest dip at ~3%, followed by the healthcare sector at more than 1.5%. The ASX Emerging Companies Index (XEC) has flatlined. For the second day in...

ASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 being the second best of the year. Ultimately, the market finished 2021 13% higher than it started. Patience pays off, unless you got in at the...

The ASX closed the second last trading day of the year – and the last full day of the year – slightly higher marking the sixth straight day of gains. This was despite a quiet day for trading and no sectors standing out with the best being t...

Highlights The ASX 200 was trading 1.6 points up at 7,511.4 in early trade. As Asia markets closed in the red on Wednesday, European stock markets closed mixed. The utilities sector is the biggest laggard today, falling 1.3%. The...

Resonance Health (RHT) receives United States Food & Drug Administration (FDA) for its new medical device LiverSmart With this FDA approval, LiverSmart will be able to be marketed and sold in the US, which is the company’s largest cust...

The Resonance Health Limited (ASX: RHT) share price is shooting the lights out on Thursday. This comes after the company announced it has received a 510(k) clearance from the US Food and Drug Administration (FDA) regarding its newest medic...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Resonance Health (RHT) submits its LiverSmart device to the FDA for US regulatory clearance LiverSmart is the company’s newest AI medical device, reviewing chest CT scans of patients with suspected pulmonary embolism The device also combin...

The ASX 200 Health Index (XHJ) is down by 0.67% at the time of writing, compared to the broader index which is up by 0.47%. Alcidion Group (ASX:ALC) rose nearly 8% this morning, after revealing that it was a member of a consortium awarded a...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Highlights The rising population and the rise in health issues are increasing the demand for healthcare products and services. People’s lifestyle is one of the reasons for rising health issues in the present times. TLX, RHT, CYC, IPD,...

The ASX 200 Health Index (XHJ) is down by 2.2% at the time of writing, compared to the broader index which is down by 0.60%. AusCann Group (ASX:AC8) is about to commence an exploratory cannabinoid (CBD) trial in people with spinal cord inju...

Wall Street mixed after previous day’s inflation-led rout US stocks closed in mixed territory on Thursday, after a selloff on Wednesday triggered by the high-inflation data release. The Dow Jones continued its slide, down by 0.34%, but the...

Perth-based medical technology company Resonance Health is gearing up to launch a new device that uses artificial intelligence to assess liver health.

Wall Street falls as IMF warns of inflation US stock markets fell for the third consecutive day, as the International Monetary Fund (IMF) cuts its global growth projection from 6.5% to 5.9%, and warned about inflation. The IMF told the BBC...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Summary The ASX 200 hit a new all-time high of 7300.5 in intraday trade on Friday, breaching Thursday’s intraday high of 7,281.8. The index closed higher for the third session, adding 35.30 points or 0.49% at 7,295.40. Bitcoin, Ether...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Tech stocks drag Wall Street lower All major indices in the US fell overnight, even as fresh data shows improvement in the US labour market. US unemployment claims fell below 400,000 for the first time since the pandemic, prompting investor...

The diagnostics imaging industry has come a long way since the days of X-rays and CT scans – two technologies that have been around for decades. Although they have not been replaced entirely, a breed of new ASX small caps have emerged over...

Wall Street mixed after a volatile week Wall Street finished on a mixed note, ending a volatile week in the US stock markets. On Friday, the Dow Jones was 0.36% higher, S&P fell 0.08%, while tech-heavy NASDAQ was down by 0.48%. Minutes...

Summary ASX-listed digital health company ResApp Health has recruited the first participant in its US-based trial to assess the link between cough and COVID-19. Botanix Pharmaceuticals revealed encouraging results from the BTX 1204A Pi...

Tech stocks lift Wall Street as iron ore tumbles 12% All major indices in US rose on Friday, with the Dow Jones climbing by 1.06%, the S&P 500 rising 1.49%, and tech-heavy NASDAQ rising by 2.32%. Tech stocks led the charge, as US Treasu...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Source: Shutterstock Summary ASX-listed medical imaging company Resonance Health has obtained CE marking to sell its device within the EEA. Resonance Health will provide HepaFat-AI to radiologists, physicians, and pharmaceutical compa...

The Resonance Health Ltd (ASX: RHT) share price rocketed more than 16% today before closing 5% higher. The booming share price moves come after the company emerged from a trading halt late this morning. This follows the release of an annou...

The Resonance Health Limited (ASX: RHT) share price has been placed in a trading halt. This comes after an announcement by the company this afternoon. Prior to the halt, the Resonance Health share price was trading narrowly higher. Rising...

Summary Medical device software of Resonance Health, HepaFat-AI added into Blackford Analysis partner agreement for distribution. Recently, HepaFat-AI had received regulatory clearance from the FDA. Resonance Health is looking forward...

The Resonance Health Limited (ASX: RHT) share price is soaring today after the company announced an agreement involving its flagship artificial intelligence (AI) device. The Resonance Health share price has surged up 9.3% to trade at 23.5...

Summary Medical imaging company Resonance Health Limited has received FDA clearance for its medical device, HepaFat-AI. The Company aims to actively take up various marketing routes for the automated medical device. The medical imagin...

The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI so...

Resonance Health (ASX:RHT) is the latest health stock to obtain FDA approval. The company’s HepaFat-AI software monitors liver health and ... Read More The post Resonance Health shares surge after its liver health monitoring software gets F...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.65% to 6,731.2 points. Four shares that are climbing more than most today are listed below....

Smartphone screen protector maker Nanoveu (ASX:NVU) is running hard this morning after receiving more proof that its antiviral screen cover can kill coronavirus — just not the one everyone is talking about. Montana lab Bioscience Laboratori...

From the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a condition characterised by debilitating chronic daily headaches and in some cases severe vision impairment. It’s a poorly treated condi...

Last year, in July, pharmaceuticals company Probiotec (ASX:PBP) announced and completed a $23m acquisition in 31 days. In its half-year report issued today the company said that purchase of contract pharmaceuticals maker ABS was largely beh...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

3DR Laboratories will now sell Resonance Health’s (RHT) FerriSmart MRI service in the United States FerriSmart uses artificial intelligence to determine the liver iron concentration from an MRI Monitoring of iron levels is important in p...

Resonance Health’s (ASX: RHT) “gold standard” FerriSmart magnetic resonance imaging service will be marketed and sold in the United Stated via an agreement with Accumen subsidiary 3DR Laboratories. FerriSmart uses artificial intelligence to...